Manvi Chemtech

PATENT RADAR — 31 APIS TRACKED

What goes generic, and when

US and EP patent positions for the APIs we work on. Off-patent molecules are open for immediate development. Informational only - verify independently before making filing decisions.

Expiry radar

202420252026202720282029203020312032203320342035todayMirabegronMirabegron - US7342117 (US) expires 2024-05-04Mirabegron - US7982049 (US) expires 2024-05-04TicagrelorTicagrelor - RE46276 (US) expires 2024-10-30AripiprazoleAripiprazole - US8017615 (US) expires 2024-12-16 - expiredRivaroxabanRivaroxaban - US7157456 (US) expires 2025-02-28BrivaracetamBrivaracetam - US6911461 (US) expires 2026-02-21Vortioxetine HBrVortioxetine HBr - US7144884B2 (US) expires 2026-07-17 - applicable only if using metal hydride salt (e.g. sodium borohydride) with Pd/C in alcoholic solvent, or metal chloride salt (zinc/tin chloride) for nitro reductionVortioxetine HBr - EP1436271 (EP) expires 2026-07-17 - same conditionLinagliptinLinagliptin - US7407955 (US) expires 2025-05-02 - expiredLinagliptin - EP1532149 (EP) expires 2026-08-30ApixabanApixaban - US6967208 (US) expires 2026-11-21Sitagliptin Phosphat…Sitagliptin Phosphate Monohydrate - US7326708 (US) expires 2027-05-24Sitagliptin Phosphate Monohydrate - EP1654263 (EP) expires 2024-06-18 - expiredEdoxaban Tosylate Mo…Edoxaban Tosylate Monohydrate - US7365205 (US) expires 2027-04-18Edoxaban Tosylate Monohydrate - EP1405852 (EP) expires 2027-06-20ApremilastApremilast - US7427638 (US) expires 2028-02-16EmpagliflozinEmpagliflozin - US7579449 (US) expires 2028-08-01CanagliflozinCanagliflozin - US7943788 (US) expires 2027-07-14Canagliflozin - EP1651658B1 (EP) expires 2028-11-19BrexpiprazoleBrexpiprazole - USRE48059B2 (US) expires 2028-12-23 - reissue of US7888362Brexpiprazole - US9206167B2 (US) expires 2026-04-12Brexpiprazole - US9480686B2 (US) expires 2026-04-12Dapagliflozin Propan…Dapagliflozin Propanediol - US6414126 (US) expires 2025-10-04Dapagliflozin Propanediol - US6515117 (US) expires 2025-10-04Dapagliflozin Propanediol - US7919598 (US) expires 2029-12-16Dapagliflozin Propanediol - EP1506211B1 (EP) expires 2028-05-14Dapagliflozin Propanediol - EP2069374B1 (EP) expires 2027-06-21ErtugliflozinErtugliflozin - US8080580 (US) expires 2030-07-13Ertugliflozin - EP2334687 (EP) expires 2033-03-22
● US patent○ EP patent● already expiredhover a dot for detail

Off-patent now (18)

Expiry timeline

MoleculePatentOfficeExpiryNote
Sitagliptin Phosphate MonohydrateEP1654263EP2024-06-18expired
LinagliptinUS7407955US2025-05-02expired
Dapagliflozin PropanediolUS6414126US2025-10-04
Dapagliflozin PropanediolUS6515117US2025-10-04
BrivaracetamUS6911461US2026-02-21
BrexpiprazoleUS9206167B2US2026-04-12
BrexpiprazoleUS9480686B2US2026-04-12
Vortioxetine HBrUS7144884B2US2026-07-17applicable only if using metal hydride salt (e.g. sodium borohydride) with Pd/C in alcoholic solvent, or metal chloride salt (zinc/tin chloride) for nitro reduction
Vortioxetine HBrEP1436271EP2026-07-17same condition
LinagliptinEP1532149EP2026-08-30
ApixabanUS6967208US2026-11-21
Edoxaban Tosylate MonohydrateUS7365205US2027-04-18
Sitagliptin Phosphate MonohydrateUS7326708US2027-05-24
Edoxaban Tosylate MonohydrateEP1405852EP2027-06-20
Dapagliflozin PropanediolEP2069374B1EP2027-06-21
CanagliflozinUS7943788US2027-07-14
ApremilastUS7427638US2028-02-16
Dapagliflozin PropanediolEP1506211B1EP2028-05-14
EmpagliflozinUS7579449US2028-08-01
CanagliflozinEP1651658B1EP2028-11-19
BrexpiprazoleUSRE48059B2US2028-12-23reissue of US7888362
Dapagliflozin PropanediolUS7919598US2029-12-16
ErtugliflozinUS8080580US2030-07-13
ErtugliflozinEP2334687EP2033-03-22